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S U M M A R Y
Background: The Xpert MTB/RIF (MTB/RIF) test has advanced the ﬁeld of tuberculosis (TB) diagnostics;
however, depending on age and HIV status, 10–85% of individuals with presumed pulmonary TB (PTB)
are unable to produce sputum.
Methods: The feasibility of using MTB/RIF and culture on stool and string test specimens from 13 adult
patients with presumed PTB was studied.
Results: The string test was well tolerated with a median Wong Baker Faces score of 2. The string test had
100% sensitivity and speciﬁcity by MTB/RIF and 87.5% sensitivity and 100% speciﬁcity by culture. In stool,
Mycobacterium tuberculosis DNA was detected in all cases of culture-conﬁrmed PTB.
Conclusion: The string test and stool provide diagnostic specimens that warrant further investigation.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Until recently, the diagnosis of pulmonary tuberculosis (PTB)
has relied on sputum smear microscopy and culture. Unfortunately
traditional culture requires at least 10–14 days and microscopy is
highly variable with 50–80% sensitivity in PTB patients without
HIV infection and 40–50% in those with HIV infection.1,2 The Xpert
MTB/RIF (MTB/RIF) test is an automated nucleic acid ampliﬁcation
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).and rifampicin resistance in 2 h with an overall diagnostic
sensitivity of 88%.3
While MTB/RIF has improved the rapidity of TB diagnostics,
limitations persist. While more sensitive than smear, MTB/RIF is
less sensitive than culture, likely related to its lower limit of
detection of 131 CFU/ml compared to 10–100 CFU/ml for sputum
culture.4 MTB/RIF fails to detect one-third of adult and 45% of
pediatric smear-negative, culture-positive cases.3,5 Further,
depending on age and HIV status, 10–85% of patients with
presumed TB are unable to produce sputum specimens.6–8 Most of
these individuals undergo further invasive diagnostic studies such
as bronchoscopy, which is often not available in resource-limited
settings. There is a need for alternative specimen collection
methods that can increase microbiologically conﬁrmed cases.3
The beneﬁt of using gastrointestinal specimens for the
diagnosis of PTB has been known since 1898, when Meunier
performed the ﬁrst gastric lavages in children. While the procedure
was mainly reserved for pediatric patients unable to expectorate,9
in 1937 Gullbring and Levin reviewed a large series of adults inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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sputum-negative PTB.10 Of interest, in ‘‘closed, benign apical
ﬁbrosis’’, currently designated as latent TB infection with cavitary
radiography, 32% of gastric lavages found TB bacilli.10
Frustrated by a progressive and extensive case of PTB with
repeated negative sputum microscopy, in 1933 Ulmar and
Ornstein performed two gastric lavages, ﬁnding TB in both.
Inspired by this success, and building upon previous work by
Hudson using iodized oil to slow the peristaltic activity of the
bronchial tree,11 Ulmar and Ornstein demonstrated the transition
of bronchial ﬂuid into the stomach by injecting iodized poppy-seed
oil into the tracheobronchial tree and performed serial roentgen-
ograms.12 Recently, with the advent of molecular diagnostics not
requiring viable organisms, there has been a resurgent interest in
novel gastrointestinal sources.13,14
Vargas et al. studied the utility of the string test in HIV-infected
individuals with presumed PTB. The string test was superior to
induced sputum in 160 cases, diagnosing 14 culture-conﬁrmed
cases compared to eight for induced sputum (p = 0.03).8 Coupled
with advances in molecular diagnostics, we sought to evaluate the
feasibility of gastrointestinal samples (string test and stool14)
using MTB/RIF.
2. Case report
In March 2014, a 64-year-old male presented with 2 weeks of
diffuse, intermittent chest pain associated with mild dyspnea, but
without cough. He had lost 10 kg in weight over the past year. He
had a past medical history of hypertension and diabetes mellitus,
and a history of colon cancer status post resection and
chemotherapy. Colonoscopy and computed tomography (CT)
examination of the chest, abdomen, and pelvis performed in
Bangladesh were negative for residual cancer. He had emigrated
from Bangladesh 1 year previously, was a former smoker with a 45-
pack-year history, and denied alcohol or illicit drug use. A physical
examination was unremarkable aside from cachexia. His hemo-
globin was 10.8 g/ml and creatinine clearance was 51 ml/min;
other laboratory studies were normal. He reported a negative
tuberculin skin test pre-immigration. His chest radiograph showed
scattered bi-apical hazy opacities and nodules. Chest CT showed
mild emphysematous changes and multiple bi-apical ill-deﬁnedTable 1
Comparison of sputum, string test, and stool by smear, culture, and MTB/RIF








Mycobacterium tuberculosis culture-positive, smear-positive
2–4+ M. tuberculosis Positive Positive P
4+ M. tuberculosis Positive Positive P
1+ M. tuberculosis Positive Positive N
3+ M. tuberculosis Positive Positive P
3+ M. tuberculosis Positive Positive P
1+ M. tuberculosis Positive Positive P
Mycobacterium tuberculosis culture-positive, smear-negative
Negative M. tuberculosis Positive Positive P
Negative M. tuberculosisa Positive Positive P
Mycobacterium tuberculosis culture-negative
1+ M. avium Negative Negative N
3+ M. kansasii Negative Negative P
Negative Negativeb UTP Negative N
Negative Negativec Negative Negative N
Negative Negatived Negative Negative N
UTP, unable to produce.
a Smear and culture were negative from induced sputum. Bronchoscopic lavage ﬂui
b Final diagnosis of Streptococcus milleri aspiration related to alcohol intoxication.
c Final diagnosis unknown/undetermined and symptoms resolved.
d Final diagnosis of interstitial lung disease related to dermatomyositis.nodules, the largest nodule measuring 2.2 cm. He had three acid-
fast bacillus (AFB) smear-negative induced sputum tests. Bron-
choscopic alveolar lavage (BAL) was AFB smear-negative. As part of
a feasibility diagnostic study, M. tuberculosis DNA was detected in
both string test and stool. The patient was started on anti-TB
therapy (ATT). The BAL ﬂuid and string test became culture-
positive 3 weeks later.
3. Methods
From August 2013 to March 2014, 13 participants were enrolled
at Ben Taub General Hospital (Houston, Texas, USA) with
presumed PTB; these patients had received <72 h of ATT. As per
routine clinical care, liquid culture (BACTEC MGIT 960) and
phenotypic drug susceptibility testing was performed on M.
tuberculosis isolated from the clinical samples acquired from
expectorated or induced sputum. The string test was performed in
the morning, after an overnight fast.8 The string capsule was
swallowed, with the trailing end taped to the cheek. Four hours
later it was removed by gentle traction, placed in 2 ml of phosphate
buffered saline, vortexed, and 1 ml was used for MTB/RIF testing
and culture.
Stool specimens were processed by two methods that do not
require centrifugation. In the sugar ﬂoatation method, 0.5 g of stool
was mechanically emulsiﬁed in 10 ml 50% Sheather’s solution.
Then the solution was manually inverted, ﬁltered through funnel
paper, and allowed to settle by gravity for 1 h. The top supernatant
(0.5 ml) was incubated in a 1:1 ratio with MTB/RIF manufacturer-
supplied NaOH and isopropanol decontamination Sample Reagent
for 30 min and then analyzed by MTB/RIF.15 In the magnetic bead
method, 0.5 g of stool was ﬁrst mixed with 1 ml of the NaOH/
isopropanol Sample Reagent solution, ﬁltered using coarse
material, mixed with the magnetic MicroSense Beads (Microsens
Medtech Ltd, London, UK) and washed twice in accordance with
the manufacturer’s instructions before being tested by MTB/RIF.
This study was performed in accordance with the principles of
the Declaration of Helsinki. Ethical approval was obtained from the
institutional review boards (IRB) of Baylor College of Medicine and
Harris Health System for Ben Taub General Hospital. All
participants provided IRB approved written informed consent










ositive Positive Positive Negative 1
ositive Positive Invalid Positive 6
egative Negative Positive Negative 2
ositive Positive Invalid Positive 2
ositive Positive Positive Positive 2
ositive Positive Positive Positive 2
ositive UTP 4
ositive Positive Invalid Negative 0
egative Negative Invalid Positive 1
ositive Negative Negative Positive 2
egative UTP 2
egative UTP 0
egative Invalid Invalid Negative 2
d was smear-negative, but culture-positive.
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Of the 13 participants with presumed PTB, eight had culture-
conﬁrmed PTB. Two subjects had non-tuberculous mycobacteria
pulmonary disease and three had other etiologies for their
symptoms. Two of the eight patients had induced or expecto-
rated sputum smear-negative, culture-positive disease. All
13 participants had successful string tests and 10 were able
to provide stool samples (see Table 1). Four participants (30%)
underwent bronchoscopic lavage as requested by their clinical
teams.
The string test placement and 4-h evaluation was well
tolerated. Minor discomfort occurred during string removal. The
median Wong–Baker Faces pain score was 2, with a range of 0 to 6
(score range of zero meaning no pain to 10 being the worst pain).
MTB/RIF on string ﬂuid had 100% sensitivity and speciﬁcity,
whereas culture of string ﬂuid had 87.5% sensitivity and 100%
speciﬁcity. The string culture and MTB/RIF assay were positive in
both cases of smear-negative disease.
Seven of eight participants with PTB were able to provide stool
within 72 h of ATT initiation. M. tuberculosis DNA from stool was
detected in seven of seven PTB subjects, using either the sugar
ﬂotation or magnetic bead procedure. The sugar ﬂotation PCR
detected four of the seven (57%) participants, while magnetic bead
concentration PCR detected six of the seven (85%) participants.
Stool culture was positive in four of seven samples. Five of 10 (50%)
stools processed with sugar ﬂotation yielded invalid results
compared to one of 10 (10%) by magnetic beads.
Rifampicin resistance was detected by sputum, string, and stool
in one case. MTB/RIF and phenotypic drug susceptibility had 100%
concordance with all specimen types.
5. Discussion
Given the limitations of current methods, the feasibility and
tolerability of the string test and stool for diagnosing PTB were
evaluated. The string test was found to be well tolerated and
provided a satisfactory sample for diagnosing PTB when used with
Xpert MTB/RIF and culture. The string test analysis with MTB/RIF
had 100% concordance with sputum culture, including detecting
both cases of smear-negative, culture-positive disease and the one
case of rifampicin resistance. A previous study using liquid and
solid media in 160 patients with HIV infection reported the string
test to be superior to sputum.8
The ﬁndings in this feasibility report suggest that the diagnostic
yield and utility of string test and stool should be compared to
sputum, the current standard of care, in a larger diagnostic study.
The string test is well-tolerated, low-risk, and simple to perform. In
patients who are unable to produce sputum, these methodsbroaden the samples available to establish a TB diagnosis and
potentially avoid more invasive procedures.
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